Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 232

    Sun Pharma looks to grow complex generics, specialty products biz faster

    Sun Pharma looks to grow complex generics, specialty products biz faster

    Medical Dialogues Bureau29 Sept 2018 9:20 AM IST
    The speciality initiative will entail incurring up-front cost and investments for long-term benefits,New Delhi: Drug major Sun Pharma has recently...
    USFDA approves Vizimpro drug to treat Lung cancer

    USFDA approves Vizimpro drug to treat Lung cancer

    Medical Dialogues Bureau29 Sept 2018 9:15 AM IST
    Vizimpro is a prescription medicine used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body.Banglore: Pfizer Inc...
    U.S. judge dismisses Teva lawsuits against Lilly on migraine drug

    U.S. judge dismisses Teva lawsuits against Lilly on migraine drug

    Medical Dialogues Bureau28 Sept 2018 9:45 AM IST
    BOSTON: A federal judge recently dismissed a pair of patent infringement lawsuits by Teva Pharmaceutical Industries Ltd that sought to block Eli Lilly...
    Nuplazid: New drug to treat Parkinsons disease

    Nuplazid: New drug to treat Parkinson's disease

    Medical Dialogues Bureau28 Sept 2018 9:20 AM IST
    As the first drug approved to treat hallucinations and delusions associated with PDP, Nuplazid was immediately popular. But lingering concerns about...
    Govt Issues Guidelines on Good Distribution Practices for pharmaceutical products, invites comments

    Govt Issues Guidelines on Good Distribution Practices for pharmaceutical products, invites comments

    Medical Dialogues Bureau27 Sept 2018 3:21 PM IST
    All the stakeholders are requested to forward their comments/ suggestions within a period of three weeks through e-mail to dci@nic.in...
    STRIKE ALERT: Chemists across India to keep doors shut on 28 September

    STRIKE ALERT: Chemists across India to keep doors shut on 28 September

    Medical Dialogues Bureau27 Sept 2018 2:07 PM IST
    We are observing one day strike on Friday, September 28, to protest any move by the government allowing the sale of medicines through an internet or...
    Suven Life Science gets product Patent from Canada and Srilanka

    Suven Life Science gets product Patent from Canada and Srilanka

    Medical Dialogues Bureau27 Sept 2018 10:15 AM IST
    Hyderabad: Suven Life Sciences Ltd has recently announced that the grant of one product patent from Canada and one product patent from Sri Lanka...
    Despite Brexit planning, EMA fears disruption for 39 medicines

    Despite Brexit planning, EMA fears disruption for 39 medicines

    Medical Dialogues Bureau27 Sept 2018 9:15 AM IST
    LONDON: Despite actions taken by companies to prepare for Brexit, there is still a risk of serious supply disruptions for 39 medicines as a result of...
    Pharma sector: Cabinet Approval for India-Uzbekistan MoU on cooperation

    Pharma sector: Cabinet Approval for India-Uzbekistan MoU on cooperation

    Medical Dialogues Bureau27 Sept 2018 9:00 AM IST
    The MoU will explore the possibilities for the production of medicines, including active pharmaceutical ingredients (APIs) in different therapeutic...
    Asia Healthcare in talks to acquire Nova IVI Fertility

    Asia Healthcare in talks to acquire Nova IVI Fertility

    Medical Dialogues Bureau26 Sept 2018 5:55 PM IST
    New Delhi: Asia Healthcare Holdings (AHH), an operating and investment platform founded by TPG Growth, the global middle market and growth equity...
    Boston Scientific introduces LithoVue Empower-kidney stone reterival device

    Boston Scientific introduces LithoVue Empower-kidney stone reterival device

    Medical Dialogues Bureau26 Sept 2018 9:48 AM IST
    The LithoVue Empower Device was developed in direct response to a need to improve procedural bottlenecks during kidney stone removal...
    Boosting profitability: Novartis to cut 2,200 jobs in Switzerland

    Boosting profitability: Novartis to cut 2,200 jobs in Switzerland

    Medical Dialogues Bureau26 Sept 2018 9:30 AM IST
    With 450 new positions being created for the production of cell and gene therapies, Swiss positions will be cut by about 1,750 net jobs.ZURICH:...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok